<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>10</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2021</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Japan’s Drug Regulation Framework: Aiming for Better Health or Bigger Profits?</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>47</FirstPage>
			<LastPage>48</LastPage>
			<ELocationID EIdType="pii">3792</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.56</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Akihiko</FirstName>
					<LastName>Ozaki</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation,
Fukushima, Japan</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Medical Governance Research Institute, Tokyo, Japan</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Yuki</FirstName>
					<LastName>Senoo</LastName>

						<AffiliationInfo>
						<Affiliation>Medical Governance Research Institute, Tokyo, Japan</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Faculty of Medicine, Comenius University, Bratislava, Slovakia</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Hiroaki</FirstName>
					<LastName>Saito</LastName>
<Affiliation>Department of
Gastroenterology, Sendai Kousei Hospital, Miyagi, Japan</Affiliation>

</Author>
<Author>
					<FirstName>Andy</FirstName>
					<LastName>Crump</LastName>
<Affiliation>Kitasato University,
Tokyo, Japan</Affiliation>

</Author>
<Author>
					<FirstName>Tetsuya</FirstName>
					<LastName>Tanimoto</LastName>
<Affiliation>Medical Governance Research Institute, Tokyo, Japan</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>03</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract></Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Drug Regulation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Gene Therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Policy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Immunotherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Japan</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Regenerative Medicines</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3792_8d84a2ac52282c304fd8617454806541.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
